Statistics
Publications
29
Citations
3.7K
H-Index
24
Active since
1980
Michael M. Hann is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacy, drug discovery, and pharmacology.
Publications per year
1980–2023
29
29
Type IIA topoisomerase inhibition by a new class of antibacterial agents
B.D. Bax, Pan F. Chan, Drake S. Eggleston et al. · Nature · 2010 · 842 citations
Xiao Qing Lewell, Duncan B. Judd, Michael M. Hann · Journal of Chemical Information and Computer Sciences · 1998 · 701 citations
Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann · MedChemComm · 2011 · 354 citations
György M. Keserű, Daniel A. Erlanson, György G. Ferenczy et al. · Journal of Medicinal Chemistry · 2016 · 233 citations
Fragment screening: an introduction
Andrew R. Leach, Michael M. Hann, Jeremy N. Burrows et al. · Molecular BioSystems · 2006 · 161 citations
1–5 of 29